X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (972) 972
Publication (47) 47
Book Review (7) 7
Book Chapter (2) 2
Newsletter (2) 2
Data Set (1) 1
Dissertation (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (469) 469
animals (452) 452
phenelzine - pharmacology (444) 444
phenelzine (400) 400
humans (397) 397
rats (326) 326
pharmacology & pharmacy (289) 289
female (248) 248
psychiatry (218) 218
adult (190) 190
monoamine oxidase inhibitors - pharmacology (181) 181
neurosciences (131) 131
middle aged (123) 123
phenelzine - therapeutic use (121) 121
antidepressive agents - pharmacology (102) 102
depressive disorder - drug therapy (94) 94
clinical neurology (88) 88
mice (88) 88
phenelzine - adverse effects (88) 88
imipramine (83) 83
index medicus (79) 79
dose-response relationship, drug (78) 78
rats, sprague-dawley (78) 78
pharmacology (77) 77
rats, inbred strains (77) 77
tranylcypromine - pharmacology (76) 76
brain - drug effects (75) 75
drug interactions (71) 71
monoamine oxidase inhibitors (71) 71
brain - metabolism (69) 69
time factors (69) 69
tranylcypromine (69) 69
monoamine oxidase inhibitors - therapeutic use (68) 68
in vitro techniques (67) 67
fluoxetine (64) 64
antidepressants (61) 61
depression (61) 61
double-blind method (61) 61
monoamine oxidase (60) 60
monoamine oxidase - metabolism (60) 60
psychiatric status rating scales (60) 60
antidepressive agents - therapeutic use (59) 59
research (55) 55
moclobemide (54) 54
aged (52) 52
serotonin - metabolism (52) 52
brain - enzymology (51) 51
serotonin (50) 50
kinetics (47) 47
depressive disorder - psychology (46) 46
imipramine - pharmacology (45) 45
monoamine oxidase inhibitors - adverse effects (44) 44
phenelzine - administration & dosage (44) 44
treatment outcome (44) 44
hydrazines - pharmacology (43) 43
double-blind (42) 42
phenelzine - metabolism (42) 42
placebo (42) 42
desipramine - pharmacology (41) 41
social phobia (40) 40
adolescent (39) 39
blood pressure - drug effects (39) 39
phobic disorders - drug therapy (39) 39
pargyline - pharmacology (38) 38
drug synergism (37) 37
metabolism (37) 37
depression - drug therapy (36) 36
nialamide - pharmacology (36) 36
panic disorder (36) 36
behavior, animal - drug effects (34) 34
dopamine (34) 34
anxiety (33) 33
rat-brain (33) 33
amitriptyline (32) 32
atypical depression (32) 32
biochemistry & molecular biology (32) 32
gamma-aminobutyric-acid (32) 32
reserpine - pharmacology (32) 32
iproniazid - pharmacology (31) 31
toxicology (31) 31
brain (30) 30
rabbits (30) 30
brain chemistry - drug effects (29) 29
chlorpromazine - pharmacology (28) 28
clinical trials as topic (28) 28
desipramine (28) 28
drug therapy (28) 28
liver - enzymology (28) 28
major depression (28) 28
dopamine - metabolism (27) 27
monoamine oxidase inhibitor (27) 27
monoamine-oxidase inhibitors (27) 27
motor activity - drug effects (27) 27
pharmacotherapy (27) 27
acetylation (26) 26
oxidases (25) 25
clorgyline - pharmacology (24) 24
imipramine - therapeutic use (24) 24
phenethylamines - pharmacology (23) 23
antidepressant (22) 22
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (893) 893
German (23) 23
Italian (19) 19
Russian (16) 16
Japanese (10) 10
French (8) 8
Chinese (7) 7
Polish (5) 5
Dutch (1) 1
Spanish (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Psychopharmacology, ISSN 0033-3158, 8/2016, Volume 233, Issue 15, pp. 2955 - 2971
Fas-associated death domain (FADD) is an adaptor of death receptors that can also induce anti-apoptotic actions through its phosphorylated form (p-FADD).... 
Neuroplasticity | Neuroprotection | Neurosciences | Biomedicine | FADD and p-FADD | Forced swim test | Anti-depressant drugs | Pharmacology/Toxicology | Psychiatry | Electroconvulsive shock | PRESYNAPTIC AUTORECEPTORS | NEUROTRANSMITTER RELEASE | PSYCHIATRY | ANTIDEPRESSANT TREATMENT | ADRENERGIC-RECEPTOR | MAJOR DEPRESSION | SUICIDE VICTIMS | NEUROSCIENCES | PREFRONTAL CORTEX | MONOAMINE-OXIDASE INHIBITORS | PHARMACOLOGY & PHARMACY | GAMMA-AMINOBUTYRIC-ACID | DEATH DOMAIN PROTEIN | Phosphoproteins - drug effects | Phenelzine - pharmacology | Autoreceptors - metabolism | Clorgyline - pharmacology | Male | Adrenergic alpha-Antagonists - pharmacology | Phosphoproteins - metabolism | Cerebral Cortex - metabolism | Idazoxan - pharmacology | Mianserin - analogs & derivatives | Mianserin - pharmacology | Desipramine - pharmacology | Fluoxetine - analogs & derivatives | Mirtazapine | Antidepressive Agents - pharmacology | Cerebral Cortex - drug effects | Phosphorylation - drug effects | RNA-Binding Proteins - antagonists & inhibitors | Fluoxetine - pharmacology | Idazoxan - analogs & derivatives | Monoamine Oxidase Inhibitors - pharmacology | Fas-Associated Death Domain Protein - drug effects | Norepinephrine Plasma Membrane Transport Proteins - antagonists & inhibitors | Fas-Associated Death Domain Protein - metabolism | Rats | Excitatory Amino Acid Antagonists - pharmacology | Blotting, Western | Brain - drug effects | Animals | CASP8 and FADD-Like Apoptosis Regulating Protein | Thiazoles - pharmacology | Ketamine - pharmacology | Electroshock | Apoptosis | Indans - pharmacology | Pharmacology, Experimental | Antidepressants | Desipramine | Fluoxetine | Psychopharmacology | Dosage and administration | Research
Journal Article
Brain Research, ISSN 0006-8993, 2008, Volume 1211, pp. 37 - 43
Journal Article
Neuropsychopharmacology, ISSN 0893-133X, 05/2009, Volume 34, Issue 6, pp. 1467 - 1481
Previous work has shown that repeated desipramine treatment causes downregulation of the norepinephrine transporter (NET) and persistent antidepressant-like... 
P-chlorophenylalanine | Norepinephrine transporter | Serotonin transporter | Antidepressant drugs | DESIPRAMINE TREATMENT | antidepressant drugs | PSYCHIATRY | DOWN-REGULATION | REBOXETINE TREATMENT | IMMOBILIZATION STRESS | REUPTAKE INHIBITORS | p-chlorophenylalanine | NEUROSCIENCES | HYDROXYLASE MESSENGER-RNA | norepinephrine transporter | serotonin transporter | MONOAMINE-OXIDASE INHIBITORS | IN-VIVO | CATECHOLAMINE DEPLETION | PHARMACOLOGY & PHARMACY | RAT-BRAIN | Depression - physiopathology | Phenelzine - pharmacology | Male | RNA, Messenger - metabolism | Brain - metabolism | Depression - drug therapy | Serotonin Plasma Membrane Transport Proteins - genetics | Norepinephrine Plasma Membrane Transport Proteins - genetics | Cyclohexanols - pharmacology | Protein Synthesis Inhibitors - pharmacology | Fenclonine - pharmacology | Monoamine Oxidase Inhibitors - pharmacology | Sertraline - pharmacology | Morpholines - pharmacology | Rats | Antidepressive Agents, Second-Generation - pharmacology | Down-Regulation - drug effects | Serotonin Antagonists - pharmacology | Rats, Sprague-Dawley | Brain - drug effects | Serotonin Plasma Membrane Transport Proteins - metabolism | Venlafaxine Hydrochloride | Protriptyline - pharmacology | Animals | Antidepressive Agents, Tricyclic - pharmacology | Norepinephrine Plasma Membrane Transport Proteins - metabolism | Serotonin Uptake Inhibitors - pharmacology
Journal Article
Journal of Pain, ISSN 1526-5900, 2016, Volume 17, Issue 4, pp. 483 - 498
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 12/1999, Volume 19, Issue 23, pp. 10494 - 10501
Journal Article
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 06/2018, Volume 175, Issue 12, pp. 2428 - 2440
Journal Article
Journal Article